Women from families with multiple cases of breast or ovarian cancer are at high risk of developing cancer, and are increasingly concerned about how they may reduce this risk. The BRCA1 gene on chromosome 17q is responsible for cancer susceptibility in most families with the breast- ovarian cancer syndrome and about one-half of families with early-onset familial breast cancer. It is the goal of this study to identify women who carry BRCA1 gene mutations from families who present for genetic counseling and to evaluate current methods of cancer prevention and detection. Carriers will be identified using chromosome 17 markers and linkage analysis. Over 30 families with hereditary breast and breast- ovarian cancer have been identified in the family cancer clinics of Creighton University and McGill University. Through collaborations with other groups and performing linkage-based genetic risk assessment, over 100 currently healthy women with BRCA1 mutations have been identified. The lifetime risk of breast cancer exceeds 80% in carriers of the BRCA1 mutation. For those women from families with ovarian cancer as well, the risk for ovarian cancer among carrier is roughly 50%. This cohort of carriers will be studied to determine the relative effectiveness of the current prevention and management alternatives for high risk women. The screening and surgical experience of each woman in the cohort and the incident cancers and the cancer deaths will be documented. The results of this prospective study will provide specific estimates of incidence and mortality rates of breast and ovarian cancer among BRCA1 carrier women who elect to have prophylactic surgical mastectomy or oophorectomy and those who choose close surveillance. The modifying effect of hormonal co-factors, inducing oral contraceptives and hormone replacement therapy on cancer incidence will also be measured. A case-control study of affected and non-affected carriers will also be carried out using the initial data set to evaluate surgical and hormonal factors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA063678-02
Application #
2105688
Study Section
Special Emphasis Panel (SRC (70))
Project Start
1994-09-15
Project End
1997-08-31
Budget Start
1995-09-01
Budget End
1996-08-31
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Mcgill University
Department
Type
DUNS #
City
Montreal
State
PQ
Country
Canada
Zip Code
H3 0-G4
Harris, Holly R; Babic, Ana; Webb, Penelope M et al. (2018) Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 27:174-182
Lu, Yingchang; Beeghly-Fadiel, Alicia; Wu, Lang et al. (2018) A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res 78:5419-5430
Liu, Gang; Mukherjee, Bhramar; Lee, Seunggeun et al. (2018) Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence. Am J Epidemiol 187:366-377
Ong, Jue-Sheng; Hwang, Liang-Dar; Cuellar-Partida, Gabriel et al. (2018) Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study. Int J Epidemiol 47:450-459
Reid, Brett M; Permuth, Jennifer B; Chen, Y Ann et al. (2017) Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci. Cancer Epidemiol Biomarkers Prev 26:116-125
Kotsopoulos, Joanne; Sopik, Victoria; Rosen, Barry et al. (2017) Frequency of germline PALB2 mutations among women with epithelial ovarian cancer. Fam Cancer 16:29-34
Kar, Siddhartha P; Adler, Emily; Tyrer, Jonathan et al. (2017) Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci. Br J Cancer 116:524-535
Rasmussen, Christina B; Kjaer, Susanne K; Albieri, Vanna et al. (2017) Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies. Am J Epidemiol 185:8-20
Akbari, Mohammad R; Zhang, Shiyu; Cragun, Deborah et al. (2017) Correlation between germline mutations in MMR genes and microsatellite instability in ovarian cancer specimens. Fam Cancer 16:351-355
Kim, Shana J; Rosen, Barry; Fan, Isabel et al. (2017) Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancer. Br J Cancer 116:964-971

Showing the most recent 10 out of 61 publications